company background image
ALIF B logo

AddLife OM:ALIF B Stock Report

Last Price

SEK 128.30

Market Cap

SEK 15.6b

7D

-4.9%

1Y

39.5%

Updated

20 Nov, 2024

Data

Company Financials +

AddLife AB (publ)

OM:ALIF B Stock Report

Market Cap: SEK 15.6b

ALIF B Stock Overview

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. More details

ALIF B fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Rewards

Trading at 19.7% below our estimate of its fair value

Earnings are forecast to grow 52.01% per year

Risk Analysis

Interest payments are not well covered by earnings

Profit margins (1.2%) are lower than last year (3.1%)

Large one-off items impacting financial results


AddLife AB (publ) Competitors

Biotage

OM:BIOT

SEK 11.8b

MedCap

OM:MCAP

SEK 7.7b

Genovis AB (publ.)

OM:GENO

SEK 1.8b

Magle Chemoswed Holding

OM:MAGLE

SEK 629.3m

Price History & Performance

Summary of all time highs, changes and price drops for AddLife
Historical stock prices
Current Share PriceSEK 128.30
52 Week HighSEK 169.80
52 Week LowSEK 88.75
Beta1.35
11 Month Change-20.01%
3 Month Change-16.58%
1 Year Change39.46%
33 Year Change-60.30%
5 Year Change93.66%
Change since IPO366.55%

Recent News & Updates

Does AddLife (STO:ALIF B) Have A Healthy Balance Sheet?

Oct 02
Does AddLife (STO:ALIF B) Have A Healthy Balance Sheet?

AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Jul 26
AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Recent updates

Does AddLife (STO:ALIF B) Have A Healthy Balance Sheet?

Oct 02
Does AddLife (STO:ALIF B) Have A Healthy Balance Sheet?

AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Jul 26
AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

AddLife's (STO:ALIF B) Weak Earnings May Only Reveal A Part Of The Whole Picture

Jul 22
AddLife's (STO:ALIF B) Weak Earnings May Only Reveal A Part Of The Whole Picture

Earnings Update: Here's Why Analysts Just Lifted Their AddLife AB (publ) (STO:ALIF B) Price Target To kr155

Jul 18
Earnings Update: Here's Why Analysts Just Lifted Their AddLife AB (publ) (STO:ALIF B) Price Target To kr155

Revenues Working Against AddLife AB (publ)'s (STO:ALIF B) Share Price

May 29
Revenues Working Against AddLife AB (publ)'s (STO:ALIF B) Share Price

Are Investors Undervaluing AddLife AB (publ) (STO:ALIF B) By 42%?

Apr 22
Are Investors Undervaluing AddLife AB (publ) (STO:ALIF B) By 42%?

Is It Time To Consider Buying AddLife AB (publ) (STO:ALIF B)?

Apr 06
Is It Time To Consider Buying AddLife AB (publ) (STO:ALIF B)?

AddLife AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models

Feb 07
AddLife AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models

AddLife AB (publ)'s (STO:ALIF B) 28% Share Price Surge Not Quite Adding Up

Dec 19
AddLife AB (publ)'s (STO:ALIF B) 28% Share Price Surge Not Quite Adding Up

AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Dec 09
AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Is It Too Late To Consider Buying AddLife AB (publ) (STO:ALIF B)?

Nov 21
Is It Too Late To Consider Buying AddLife AB (publ) (STO:ALIF B)?

Is There An Opportunity With AddLife AB (publ)'s (STO:ALIF B) 43% Undervaluation?

Oct 14
Is There An Opportunity With AddLife AB (publ)'s (STO:ALIF B) 43% Undervaluation?

AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Sep 08
AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Is Now The Time To Look At Buying AddLife AB (publ) (STO:ALIF B)?

Aug 18
Is Now The Time To Look At Buying AddLife AB (publ) (STO:ALIF B)?

Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Jul 05
Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Is Now An Opportune Moment To Examine AddLife AB (publ) (STO:ALIF B)?

May 18
Is Now An Opportune Moment To Examine AddLife AB (publ) (STO:ALIF B)?

Is AddLife (STO:ALIF B) Using Too Much Debt?

Apr 28
Is AddLife (STO:ALIF B) Using Too Much Debt?

AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

Apr 05
AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

Feb 21
AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

AddLife (STO:ALIF B) Has Announced That Its Dividend Will Be Reduced To SEK1.20

Feb 07
AddLife (STO:ALIF B) Has Announced That Its Dividend Will Be Reduced To SEK1.20

Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

Jan 20
Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

AddLife (STO:ALIF B) Has A Pretty Healthy Balance Sheet

Dec 30
AddLife (STO:ALIF B) Has A Pretty Healthy Balance Sheet

Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Oct 27
Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

Oct 11
Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

Is AddLife (STO:ALIF B) A Risky Investment?

Sep 23
Is AddLife (STO:ALIF B) A Risky Investment?

When Should You Buy AddLife AB (publ) (STO:ALIF B)?

Jul 11
When Should You Buy AddLife AB (publ) (STO:ALIF B)?

Is AddLife (STO:ALIF B) Using Too Much Debt?

Jun 25
Is AddLife (STO:ALIF B) Using Too Much Debt?

Shareholder Returns

ALIF BSE Life SciencesSE Market
7D-4.9%-7.4%-1.9%
1Y39.5%23.1%12.5%

Return vs Industry: ALIF B exceeded the Swedish Life Sciences industry which returned 23.1% over the past year.

Return vs Market: ALIF B exceeded the Swedish Market which returned 12.5% over the past year.

Price Volatility

Is ALIF B's price volatile compared to industry and market?
ALIF B volatility
ALIF B Average Weekly Movement4.7%
Life Sciences Industry Average Movement6.4%
Market Average Movement5.5%
10% most volatile stocks in SE Market11.2%
10% least volatile stocks in SE Market3.3%

Stable Share Price: ALIF B has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: ALIF B's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19062,356Fredrik Dalborgwww.add.life

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments.

AddLife AB (publ) Fundamentals Summary

How do AddLife's earnings and revenue compare to its market cap?
ALIF B fundamental statistics
Market capSEK 15.64b
Earnings (TTM)SEK 117.00m
Revenue (TTM)SEK 10.01b

133.6x

P/E Ratio

1.6x

P/S Ratio

Is ALIF B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALIF B income statement (TTM)
RevenueSEK 10.01b
Cost of RevenueSEK 6.28b
Gross ProfitSEK 3.74b
Other ExpensesSEK 3.62b
EarningsSEK 117.00m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 05, 2025

Earnings per share (EPS)0.96
Gross Margin37.31%
Net Profit Margin1.17%
Debt/Equity Ratio95.9%

How did ALIF B perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

52%

Payout Ratio